Company news

Ionis Pharmaceuticals, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Akcea and Ionis Announce Initiation of NEURO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with Polyneuropathy Driven by Hereditary TTR Amyloidosis

November 24, 2019

Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx)

November 18, 2019

Ionis Pharmaceuticals to hold third quarter 2019 financial results webcast

October 21, 2019

Ionis' Factor XI anti-thrombotic medicine advances with Bayer following positive clinical results

October 8, 2019

Ionis licenses hepatitis B program to GSK

August 26, 2019

Ionis Reports Second Quarter 2019 Financial Results

August 6, 2019

Ionis Pharmaceuticals to hold second quarter 2019 financial results webcast

July 29, 2019

Ionis announces appointment of Joan E. Herman to its board of directors

June 11, 2019

Ionis launches new corporate brand that reflects company's industry-leading innovation and unique culture of saying "yes" to patients

May 5, 2019

← Newer news releases

Calls

The 5 newest of 26 calls. Every call is listed under its year.

Decks

The 5 newest of 20 decks. Every deck is listed under its year.